Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015, Article ID 693234, 8 pages
http://dx.doi.org/10.1155/2015/693234
Research Article

A Biomimic Reconstituted High Density Lipoprotein Nanosystem for Enhanced VEGF Gene Therapy of Myocardial Ischemia

1Department of Cardiac Surgery, Zhongshan Hospital of Fudan University and Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai 200032, China
2Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University, Shanghai 200040, China

Received 7 December 2014; Accepted 18 March 2015

Academic Editor: Takuya Tsuzuki

Copyright © 2015 Xiaotian Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Chockalingam, J. Chalmers, L. Lisheng et al., “Prevention of cardiovascular diseases in developing countries: agenda for action (statement from a WHO-ISH meeting in Beijing, October 1999),” Journal of Hypertension, vol. 18, no. 12, pp. 1705–1708, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kawamoto, H.-C. Gwon, H. Iwaguro et al., “Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia,” Circulation, vol. 103, no. 5, pp. 634–637, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Mitsos, K. Katsanos, E. Koletsis et al., “Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials,” Angiogenesis, vol. 15, no. 1, pp. 1–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-J. Kang, H.-S. Kim, S.-Y. Zhang et al., “Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial,” The Lancet, vol. 363, no. 9411, pp. 751–756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Yanagisawa-Miwa, Y. Uchida, F. Nakamura et al., “Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor,” Science, vol. 257, no. 5075, pp. 1401–1403, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. F. R. Formiga, E. Tamayo, T. Simón-Yarza, B. Pelacho, F. Prósper, and M. J. Blanco-Prieto, “Angiogenic therapy for cardiac repair based on protein delivery systems,” Heart Failure Reviews, vol. 17, no. 3, pp. 449–473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Wang, J. Rosano, D. L. Crabbe, and M. F. Kiani, “Targeted delivery of VEGF to treat myocardial infarction,” in Oxygen Transport to Tissue XXXIV, vol. 765 of Advances in Experimental Medicine and Biology, pp. 307–314, Springer, New York, NY, USA, 2013. View at Publisher · View at Google Scholar
  8. J. Kastrup, E. Jørgensen, A. Rück et al., “Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study: the Euroinject One trial,” Journal of the American College of Cardiology, vol. 45, no. 7, pp. 982–988, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Rajagopalan, E. R. Mohler III, R. J. Lederman et al., “Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication,” Circulation, vol. 108, no. 16, pp. 1933–1938, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. F. R. Formiga, B. Pelacho, E. Garbayo et al., “Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model,” Journal of Controlled Release, vol. 147, no. 1, pp. 30–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. K. Rosengart, L. Y. Lee, S. R. Patel et al., “Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease,” Circulation, vol. 100, no. 5, pp. 468–474, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. A. N. McGinn, H. Y. Nam, M. Ou et al., “Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium,” Biomaterials, vol. 32, no. 3, pp. 942–949, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Wang, X. Bao, X. Ding et al., “A multifunctional self-dissociative polyethyleneimine derivative coating polymer for enhancing the gene transfection efficiency of DNA/polyethyleneimine polyplexes in vitro and in vivo,” Polymer Chemistry, vol. 6, no. 5, pp. 780–796, 2015. View at Publisher · View at Google Scholar
  14. P. Linsel-Nitschke and A. R. Tall, “HDL as a target in the treatment of atherosclerotic cardiovascular disease,” Nature Reviews Drug Discovery, vol. 4, no. 3, pp. 193–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Collet, A. R. Tall, H. Serajuddin et al., “Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor BI,” Journal of Lipid Research, vol. 40, no. 7, pp. 1185–1193, 1999. View at Google Scholar · View at Scopus
  16. M. L. Fitzgerald, Z. Mujawar, and N. Tamehiro, “ABC transporters, atherosclerosis and inflammation,” Atherosclerosis, vol. 211, no. 2, pp. 361–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. K. Shahzad, L. S. Mangala, H. D. Han et al., “Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles,” Neoplasia, vol. 13, no. 4, pp. 309–319, 2011. View at Google Scholar
  18. K. C. Vickers, B. T. Palmisano, B. M. Shoucri, R. D. Shamburek, and A. T. Remaley, “MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins,” Nature Cell Biology, vol. 13, no. 4, pp. 423–435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. A. Bull, S. H. Bailey, J. J. Rentz et al., “Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction: VEGF gene therapy for myocardial infarction,” Journal of Controlled Release, vol. 93, no. 2, pp. 175–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-W. Won, A. N. McGinn, M. Lee, K. Nam, D. A. Bull, and S. W. Kim, “Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia,” Biomaterials, vol. 34, no. 26, pp. 6229–6238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Benavides-Vallve, D. Corbacho, O. Iglesias-Garcia et al., “New strategies for echocardiographic evaluation of left ventricular function in a mouse model of long-term myocardial infarction,” PLoS ONE, vol. 7, no. 7, Article ID e41691, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Simoń-Yarza, E. Tamayo, C. Benavides et al., “Functional benefits of PLGA particulates carrying VEGF and CoQ10 in an animal of myocardial ischemia,” International Journal of Pharmaceutics, vol. 454, no. 2, pp. 784–790, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. He, Y. Hu, L. Yin, C. Tang, and C. Yin, “Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles,” Biomaterials, vol. 31, no. 13, pp. 3657–3666, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. K. Limbach, Y. Li, R. N. Grass et al., “Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations,” Environmental Science and Technology, vol. 39, no. 23, pp. 9370–9376, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Bao, W. Wang, C. Wang et al., “A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy,” Biomaterials, vol. 35, no. 29, pp. 8450–8466, 2014. View at Publisher · View at Google Scholar
  26. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan, “Toxicity of cationic lipids and cationic polymers in gene delivery,” Journal of Controlled Release, vol. 114, no. 1, pp. 100–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Ding, Y. Wang, J. Zhou et al., “Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis,” Biomaterials, vol. 35, no. 25, pp. 7214–7227, 2014. View at Publisher · View at Google Scholar · View at Scopus